An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time oncology review, expediting access to this potential treatment. The FDA has ...

The report highlights the impact of US tariffs on global trade dynamics and the increased focus on the Global South. ANI India will face over USD 14.6 bn in additional duties, if US imposes 20 per ...